Japan Mulls Longer Drug Patents
Japan's Ministry of Health, Labour and Welfare is considering whether to extend the the country's patent protection period for new drug products in order to provide manufacturers with better research incentives and profits, the Nihon Keizai Shimbun reported.
Sales of generic versions are banned for six years in Japan, during which new drugs enjoy high government-set prices.
Comparable protection in major European countries covers about...
To view the full article, register now.